Zhejiang Huakang Pharmaceutical Co., Ltd. Class ASSE: 605077

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Progress in Providing Guarantee Limit for Wholly-owned Subsidiary

Aug 27, 2026 · Issued by Zhejiang Huakang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Progress in Providing Guarantee Limit for Wholly-owned Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhejiang Huakang Pharmaceutical Co., Ltd. Class A

"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Completion of Repurchase and Cancellation of Certain Restricted Shares and Adjustment to the Conversion Price of "Huakang Convertible Bonds"Aug 25
"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Resolutions of the 4th Meeting of the 7th Board of DirectorsAug 21
"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on the Implementation of the Repurchase and Cancellation of Certain Restricted Shares under the Equity Incentive PlanAug 19
"Zhejiang Huakang Pharmaceutical Co., Ltd."Announcement on Not Revising Downward the Conversion Price of "Huakang Convertible Bonds"Jul 22

All Zhejiang Huakang Pharmaceutical Co., Ltd. Class A news releases